⌘K

Login Start Free

OPTIMER PHARMACEUTICALS INC·4

Sep 1, 4:55 PM ET

Shue Youe Kong 4

4 · OPTIMER PHARMACEUTICALS INC · Filed Sep 1, 2010

Insider Transaction Report

Form 4

Period: 2010-08-30

OPTIMER PHARMACEUTICALS INCOPTR

VP, clinical Development

Transactions

Exercise/Conversion
Common stock
2010-08-30$2.17/sh+4,326$9,373→ 90,107 total
Exercise/Conversion
Common stock
2010-08-30$1.08/sh+1,875$2,031→ 85,781 total
Exercise/Conversion
Stock option (right to buy)
2010-08-30−4,326→ 0 total
Exercise: $2.17Exp: 2016-09-13→ Common stock (4,326 underlying)
Exercise/Conversion
Stock option (right to buy)
2010-08-30−1,875→ 0 total
Exercise: $1.08Exp: 2013-11-14→ Common stock (1,875 underlying)
Exercise/Conversion
Common stock
2010-08-30$1.08/sh+97$105→ 83,906 total
Exercise/Conversion
Stock option (right to buy)
2010-08-30−97→ 0 total
Exercise: $1.08Exp: 2013-02-13→ Common stock (97 underlying)

Footnotes (1)

[F1]Options are exercisable immediately.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT